This brand name is authorized in Japan, United States
The drug RECLAST contains one active pharmaceutical ingredient (API):
|
1
Zoledronic acid
UNII 6XC1PAD3KF - ZOLEDRONIC ACID
|
|
Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption. |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3999423A4027 |
| Country: US | FDA, National Drug Code | Identifier(s): 0078-0435 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
